FINWIRES · TerminalLIVE
FINWIRES

Entropy Neurodynamics Files US Patent Application After Clinical Insights From Phase 2A IBS Study, Shares Down 5%

By

-- Entropy Neurodynamics (ASX:ENP) filed a US provisional patent application based on clinical insights from the results of its phase 2a study of TRP-8802, or oral psilocybin, in patients with treatment-resistant, irritable bowel syndrome (IBS), according to a Tuesday Australian bourse filing.

The filing is in addition to its existing international patent application related to psychedelic-assisted therapy for disorders of gut-brain interaction, which was filed under the Patent Cooperation Treaty on Jan. 3, 2024.

The results highlighted a 75% response rate in treatment-resistant IBS patients, which the firm noted was the strongest clinical signal ever reported in IBS drug development.

Its shares fell 5% in recent trading on Tuesday.

Related Articles

International

RBA Press Conference: Oil Shock Will Worsen Housing Crises, Says Bullock

$^AXJO
Asia

Lehar Footwears Plans to Set Up New Footwear Manufacturing Unit in Haryana, India; Shares Up 3%

Lehar Footwears (BOM:532829) plans to establish a new manufacturing unit in Haryana, India, to strengthen its presence in the athleisure and sports footwear market, according to a Tuesday filing to the Indian stock exchanges.The company has already signed a rent agreement for the proposed facility, which is expected to commence commercial operations in the second quarter of the financial year 2026.The new facility will focus on manufacturing sports shoes and related products. It will help the company scale up production capacity from around 100,000 pairs per month to 500,000 pairs per month in a phased manner.The company's shares were up nearly up 3% in recent trade.

$BOM:532829
Asia

New Zealand Shares Fall; Fletcher Building Flags Ongoing Residential Review, Asset Sales Underway

New Zealand shares ended lower on Tuesday as most Asian indexes saw losses amid fresh attacks exchanged between the US and Iran over the Strait of Hormuz.The S&P/NZX 50 Index fell 0.47% or 61.98 points to close at 13,035.70.The US and Iran exchanged fresh strikes across the Gulf on Monday, vying for control of the Strait of Hormuz with rival maritime blockades and rattling an already fragile truce, according to a Monday Reuters report.Meanwhile, New Zealand signed an agreement with Singapore on Monday to keep supply chains open between the countries during times of crisis, according to a Monday Reuters report.In domestic news, the ANZ World Commodity Price Index fell 0.8% month over month in April, with dairy prices in a period of high volatility, particularly butter and anhydrous milk fat, according to a report from ANZ Research.Further, overall card spending fell 2.5% in April, but was up 4.4% compared with the same time last year, ANZ Research said in a note.In corporate news, Fletcher Building (ASX:FBU, NZE:FBU) acknowledged recent media reports about its ongoing strategic review of the residential and development division, including speculation around a potential industrial property sale, but declined to provide further comment.Synlait Milk (ASX:SM1, NZE:SML) obtained two waivers in relation to its syndicated loan facilities, as external challenges continue to strain the company's financial performance.

$^NZ50$ASX:FBU$ASX:SM1$NZE:FBU$NZE:SML